Prostate-specific antigen (PSA) is the most frequently used screening test for PCa, which was first introduced into clinical use in 1980 s and promoted the detection rate of PCa significantly.[6,7] But there has always been controversy over PSA screenings for men since its application. Here, KLK3 is linked to posterior cortical atrophy.